Remove tag reimbursement
article thumbnail

Insurance Coverage for Psychedelic Therapy

Bill of Health

By Vincent Joralemon As therapies using drugs like MDMA, psilocybin, and LSD advance through the FDA research and approval pipeline, patients should be prepared for steep price tags attached to these procedures. Although this may be highly cost-effective (considering the cost of untreated PTSD), insurers may balk at the price tag.

FDA 201
article thumbnail

Waystar's Hawkins weighs in on future of telehealth reimbursement

Healthcare IT News - Telehealth

Primary topic: Telehealth Disable Auto Tagging: Short Headline: Waystar's Hawkins weighs in on future of telehealth reimbursement Featured Decision Content: Region Tag: Global Edition Right Now:

81
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Telemedicine is a major driver in shifting the healthcare delivery model

Healthcare IT News - Telehealth

With desperation being the mother of innovation, barriers such as physician resistance, insurance carrier reimbursement and government regulation have been rapidly overcome. Region Tag: Global Edition Disable Auto Tagging: Short Headline: Telemedicine is a major driver in shifting the healthcare delivery model Featured Decision Content:

article thumbnail

Healthcare Providers Take Notice: AMA Updates E/M Codes for 2021

McBrayer Law Blog

These changes, proposed by the Centers for Medicare & Medicaid Services (‘CMS’), primarily impact 2021 Medicare Physician Fee Schedule (‘MPFS’) reimbursements.

article thumbnail

Has telehealth hit the high watermark?

Healthcare IT News - Telehealth

The ever-present uncertainties of healthcare reimbursement somewhat dampen the gung-ho rhetoric on telehealth. In a swift and welcome response to COVID-19, the CMS announced rules to improve telehealth reimbursements across the board. Following the money. Featured Decision Content:

COVID-19 137
article thumbnail

The $2.8M Medicine: How Data Can Help Insurers Pay for Life-Changing Therapies Without Breaking The Bank

HIT Consultant

Many of these treatments are drug-based gene therapies–- but they come with an extremely high price tag. For example, bluebird has already (admirably) said that it would be willing to reimburse insurance companies up to 80% of the cost of its new gene therapy, called Zynteglo, if patients are not able to stop relying on blood transfusions.

article thumbnail

A look back on 2020: reshaping the healthcare IT landscape

Healthcare IT News - Telehealth

The technology existed for many years, but organizations were slow to adopt this technology for a variety of reasons, including restrictions in reimbursement and lack of operational workflows. Here's hoping that our actions will be dictated by "assurance" rather than desperation.